Meeting
2023 ASCO Annual Meeting
Clinical application of ctDNA detection in Chinese pediatric patients with soft tissue sarcoma (STS).
Authors
Jia Zhu
Sun Yat-sen University Cancer Center, Guangzhou, China
Jia Zhu , Suying Lu , Juan Wang , Feifei Sun , Junting Huang , Yi Que , Zijun Zhen , Xiaofei Sun , Yizhuo Zhang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10041)
DOI
10.1200/JCO.2023.41.16_suppl.10041
Abstract #
10041
Poster Bd #
347
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Evaluating metrics of circulating tumor DNA response and progression using a high sensitivity tumor-agnostic assay in metastatic HR+/HER2- breast cancer receiving endocrine therapy and a CDK4/6-inhibitor.
First Author: Mitchell Elliott
Poster
2022 ASCO Annual Meeting
Phase I study of pegylated liposomal doxorubicin in combination with cyclophosphamide and vincristine in pediatric patients with relapsed/refractory sarcoma and other malignant solid tumors.
First Author: Suying Lu
Poster
2014 ASCO Annual Meeting
Phase II trial of cixutumumab in combination with temsirolimus in pediatric patients with recurrent or refractory sarcoma: A report from the Children’s Oncology Group.
First Author: Lars M. Wagner
Poster
2024 ASCO Breakthrough
Circulating tumor DNA for predicting radiographic and pathologic response to total neoadjuvant therapy in locally advanced rectal cancer: ENSEMBLE-1.
First Author: Yoshinori Kagawa